Skip to main content
Caplight Logo









AdBio partners

AdBio partners

Overview

AdBio partners is a life sciences venture capital firm that invests in early-stage therapeutic-oriented projects and supports the development of innovative startups in Europe.

Year Founded

2016

AUM

$65M

Portfolio Companies

16

Investments

AdBio partners investments
CompanyDateStageLead
AgomAb TherapeuticsMar 2021Series BCo-investor
AndzonBio1Oct 2024SeedCo-investor
CephagenixJan 2025SeedLead
DiogenXMay 2023Series ACo-investor
Alderaan BiotechnologyJan 2020Series ALead
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Alain Huriez

Chairman & Managing Partner

Clément Bertholet

Managing Partner

Jacques Dumas

Venture Partner

Mounia Azzi

Partner

Adrien C.

Principal - AdBio Partners

Book a demo to see all key people

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is AdBio partners based?

AdBio partners is headquartered in Paris, France.

When was AdBio partners founded?

AdBio partners was founded in 2016.

How many portfolio companies does AdBio partners have?

AdBio partners has 16 portfolio companies in Caplight's dataset.

What are some companies in AdBio partners's portfolio?

Portfolio companies visible on Caplight include AgomAb Therapeutics, AndzonBio1, Cephagenix, DiogenX, Alderaan Biotechnology.

What was AdBio partners's most recent investment shown here?

AdBio partners's most recent investment in this portfolio sample was in Cephagenix in 2025.

What sectors does AdBio partners focus on?

AdBio partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does AdBio partners focus on?

Stage focus information for AdBio partners is not publicly available.

What is AdBio partners's AUM?

AdBio partners's assets under management are estimated between $185.3M and $185.3M.

Firmographic Details

HeadquartersParis
Year Founded2016
AUM$65M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?